N2Growth Blog

JANUARY 10, 2024

With the guidance and support of experienced executive search consultants, companies can strengthen their leadership teams and drive innovation, growth, and success in the life sciences industry. The rapid pace of innovation and advancement in the sector further compounds the challenges of leadership recruitment.

Execution 243

Execution Leadership Pipeline Leadership Diversity 243

The Horizons Tracker

APRIL 11, 2023

A recent study from Texas A&M University looks at the role innovation potential can play in terms of providing a sufficiently credible signal to reduce the impact insider sales have on perceptions of quality. “Our research, however, documents a positive effect on IPO valuation from informing investors of future innovation plans.

IPO 115

IPO Reference Innovation Pharmaceuticals 115

The Horizons Tracker

NOVEMBER 3, 2024

In terms of innovation and collaboration, it’s well known that proximity plays a big role in whether we create or innovate with others. Moving around The researchers used a pharmaceutical company to conduct their experiment, with the company relocating their regional offices in Singapore and Kuala Lumpur respectively.

Pharmaceuticals 69

Pharmaceuticals Long-term Bond Cooper 69

The Horizons Tracker

NOVEMBER 23, 2020

The coronavirus pandemic has thrust the healthcare and pharmaceutical industries into the limelight like never before. The analysis found that healthcare and pharma are neck and neck with the technology sector in terms of the area people would consider moving to, with both easily beating sectors such as finance and telecoms.

Industry 100

Industry Pharmaceuticals Technology Finance 100

The Horizons Tracker

MARCH 2, 2020

The growth in electronic medicines offers significant potential to better monitor the effectiveness of treatments, but new research from the University of Copenhagen also highlights the ethical and legal complications the technology brings. New capabilities. There are also issues surrounding the ownership of the patient’s data.

Ethics 76

Ethics Pharmaceuticals Uncertainty Self-aware 76

Leading Blog

AUGUST 14, 2018

Steinway & Sons spiraled into decline “in large part due to its myopic obsession with craftsmanship at the expense or technological advancement and automation.” We can’t stand on what got us here, we must innovate. * * * Like us on Instagram and Facebook for additional leadership and personal development ideas. * * *.

How To 177

How To Core Competence Pharmaceuticals Creativity 177

The Horizons Tracker

JUNE 9, 2021

As AI has become more potent, there have been understandable concerns about how the technology can be policed so that it works for the benefit of all society rather than certain sections of it. A new paper from Lancaster University explores how AI can be effectively policed, and indeed who should do the policing. Trusting AI.

Document 88

Document Pharmaceuticals Discount Technology 88

Strategy Driven

DECEMBER 18, 2020

Financial Technology Will Be in Higher Demand. As more businesses move to virtual formats, the need for financial technology will continue to increase in 2021. Gayhardt states that Hong Kong is already increasing its use of advanced fraud detection, biometric facial recognition, and other innovative AI technologies due to the pandemic.

Retail 79

Retail Supply Chain Pharmaceuticals Technology 79

The Horizons Tracker

SEPTEMBER 15, 2019

model, which is supported by the Estonian government, demonstrates the paths to new business models that focus not only on providing services, but also on fostering a collaborative platform for all to innovate. The E-Residency initiative and its succeeding 2.0

Pharmaceuticals 70

Pharmaceuticals Entrepreneur Politics Globalization 70

Tanveer Naseer

MARCH 10, 2015

The following is a guest piece by Innovation Excellence co-founder Rowan Gibson. What most companies understand now is that the only way to drive profitable growth and wealth creation over the longer term is to innovate. But that’s not the way radical innovators envisage their organizations. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

The Horizons Tracker

MAY 2, 2023

These CEOs had transitioned through the classes as a result of their educational performance and were highly present in sectors like technology, engineering, health, and education. .” Knowledge intensive There was also a preponderance of “social-class transitioners” in knowledge-intense industries.

Class 127

Class CEO Education Engineering 127

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. The researchers highlight the particular impact on businesses in the travel and hospitality sectors, who have all suffered due to the lockdown measures. Face-to-face interactions.

Pharmaceuticals 72

Pharmaceuticals Transportation Retail Long-term 72

The Horizons Tracker

FEBRUARY 22, 2022

That we’re still largely waiting for such an immersive world to take hold, despite much-hyped initiatives, such as Second Life, perhaps underlines the difficulties the technology has had in keeping pace with such a vision. Digital twins. It’s a market that is already worth $3.1

Stephenson 110

Stephenson Wireless Christensen Automotive 110

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. “Japanese leaders recognize the importance of encouraging medical innovation,” Eli Lilly and Co. Older people need more medicine.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Content 8

The Horizons Tracker

OCTOBER 9, 2019

Countries around the world have made a concerted effort to try and encourage more young people to take an interest in science, technology, engineering and maths (STEM), with an understandable belief that these topics are vital for the competitive edge of a modern economy.

Pharmaceuticals 73

Pharmaceuticals Education ROI Project 73

First Friday Book Synopsis

MARCH 21, 2012

An entrepreneur and veteran of the computer industry, Frank Moss spent his career bringing innovative technologies to market. Ten years ago he set out to make a broader contribution to the world, leading him to cofound a cancer drug discovery company and then to the MIT Media Lab, where he served as director from 2006 [.].

Entrepreneur 80

Entrepreneur Media Technology Innovation 80

Harvard Business Review

JULY 8, 2016

China has not been a huge technology innovator, despite being the world’s second-largest investor in R&D , but Chinese businesses have found ways to use innovations in processes, business models, and customer experience to their disruptive advantage. This presents Western companies with a fresh challenge.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

MAY 7, 2015

Recently, information technology research and advisory company Gartner compiled a list of top 10 strategic technology trends. In the pharmaceutical industry, technology is transforming the sales process. In the pharmaceutical industry, technology is transforming the sales process. Computing everywhere.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

JUNE 26, 2014

In his 2008 book Patent Failure , Bessen and co-author Michael Meurer argue that after taking the cost of litigation into account, the effect of patenting in all industries except pharmaceuticals and chemicals was to reduce the profitability of innovation rather than to increase it. Innovation Technology'

Innovation 9

Innovation Pharmaceuticals Chemicals Software 9

Strategy Driven

NOVEMBER 29, 2016

Always at the forefront of innovation, technologies pioneered by the military are often adopted by the commercial sector; companies looking for cyber knowledge or network engineering skills can find this expertise among veterans.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Strategy Driven

JULY 13, 2011

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). As with the other measures, what is important varies by industry.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

JUNE 7, 2012

Take technology providers' technical support, with its long hold times "hopelessly complex interactions." Pharmaceutical patent expirations are increasing the use of cheaper generic drugs. Looking to take an unsuspecting industry by storm? To start, try eliminating customer pain points. BONUS BITS: Life-Saving Goes Social.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. At the same time, the marketplace has become so fiercely competitive—and investors so demanding—that few are willing to take a flyer on an unproven technology.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Disruptive innovations are: Cheaper (from a customer perspective). Because disruptive products were cheaper, more accessible, and built on new technology architectures, they tended to be crummier than the existing highest-end solutions.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. “To be able to do that, they need to entice companies to come to Japan, and they need to entice their own pharmaceutical companies to license in and obtain the best.” Agilis Biotherapeutics, a U.S.

Pharmaceuticals 8

Pharmaceuticals Content Licensing Trends 8

Harvard Business Review

OCTOBER 11, 2013

Four years ago, Craig Hatkoff, co-founder of the Tribeca Film Festival, approached me about a brainstorm: an event recognizing and celebrating breakthrough innovators. When I suggested to Clayton Christensen that we partner with Hatkoff to create the Tribeca Disruptive Innovation Awards , Clay’s response was : I trust you Whitney.

Innovation 12

Innovation Christensen Decisionmaking CTO 12

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 14

Innovation Company Biotechnology CFO 14

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 15

Health Care Innovation Pharmaceuticals Consensus 15

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K.

Globalization 11

Globalization Innovation Decentralization Chemicals 11

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 14

Innovation Supply Chain Offshoring Policies 14

Harvard Business Review

FEBRUARY 20, 2018

Today, in pharmaceuticals and medical devices, in health care services and regenerative medicines, non-Japanese firms are learning from Japan’s markets before the aging trend arrives elsewhere in the world. From Finland to Israel, from Australia to Portugal, from the U.S.

Pharmaceuticals 8

Pharmaceuticals Company Content Health Care 8

Harvard Business Review

JUNE 7, 2012

Take technology providers' technical support, with its long hold times "hopelessly complex interactions." Pharmaceutical patent expirations are increasing the use of cheaper generic drugs. Looking to take an unsuspecting industry by storm? To start, try eliminating customer pain points. BONUS BITS: Life-Saving Goes Social.

Disruptive Innovation 14

Disruptive Innovation Innovation Pharmaceuticals Class 14

Harvard Business Review

SEPTEMBER 28, 2020

Sponsor content from Indegene.

Pharmaceuticals 10

Pharmaceuticals Content Industry Technology 10

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. Innovating for Value in Health Care. Insight Center. Sponsored by Medtronic.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8